Product Information

METHIMAZOLE 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0694 per EA under NDC 64980026401. Its NADAC has been published 184 times since May 10, 2023.

FDA first approved this application on Mar 7, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHIMAZOLE 5 MG TABLET

methimazole
$0.0694per EA

Strength

5 mg/1

NDC

64980026401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

METHIMAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA202068

FDA Approved

3/7/2012

TE Code

AB

On Market Since

4/22/2021

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for METHIMAZOLE 5 MG TABLET has been published 184 times since May 10, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0694 per EA
All-time high$0.1140 (Sep 13, 2023)
All-time low$0.0661 (Nov 20, 2024)
52-week high$0.0788
52-week low$0.0694
Median price$0.0786
Average price$0.0802
Largest weekly change+27.3% (Aug 23, 2023)
Weeks tracked184
Tracking sinceMay 10, 2023

Price History

1W

0.0%

1M

-1.2%

3M

-1.9%

6M

-3.6%

1Y

-16.4%

3Y

-27.0%

5Y

N/A

All

+0.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHIMAZOLE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0694 per EA (NDC 64980026401), effective Nov 11, 2026.

How has the price of METHIMAZOLE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 184 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?

Since May 10, 2023, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0661 (Nov 20, 2024) to a high of $0.1140 (Sep 13, 2023), with a median of $0.0786 per EA.

Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHIMAZOLE 5 MG TABLET?

METHIMAZOLE 5 MG TABLET (NDC 64980026401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.